FEATURE: Patents Not Enough to Protect Affy from Onslaught of Competition | GenomeWeb

NEW YORK, Nov 1 - When Affymetrix entered the uncharted waters of DNA chips in 1991, microarrays were highly specialized and complex tools that few companies were ready to market or use.

But over the past few years, many companies have begun to understand the underlying technology and find ways to circumvent Affy’s host of over 300 protective patents, pointing to the possibility that these tools could become commodity items.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.